Goodwin’s Capital Markets team advised The Chemours Company (“Chemours”) on its private offering of $700,000,000 in aggregate principal amount of 7.875% senior unsecured notes due 2034 (the “Notes”) that was exempt from the registration requirements of the Securities Act of 1933, as amended. The Notes are Chemours’ senior unsecured obligations and are guaranteed by one of its subsidiaries. The net proceeds of the offering were used to fund the partial redemption of Chemours’ outstanding 5.750% senior notes due 2028, and the remaining net proceeds are expected to be used to fund the redemption of Chemours’ outstanding 5.375% senior notes due 2027.
The Chemours Company is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas.
The Goodwin team was led by David Lynn, Jim Barri, and Jon Burr and included Brandon Richards, Rachel Staats, Anna Dodson, Ali O’Keeffe, Anna Jones, Dan Karelitz, Garrett Gaughan, Bibek Pandey, Hasan Cetin, Brynn Peltz, Ettore Santucci, and Gaby Boria.
For more information on the deal, please read the pricing press release and closing press release.